Syndax Pharmaceuticals Inc (SNDX) reports promising revenue from Revv Forge launch and outlines strategic growth plans, ...

Equities research analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for shares of Syndax ...

HC Wainwright restated their buy rating on shares of Syndax Pharmaceuticals (NASDAQ:SNDX – Free Report) in a report published ...

Highlights,Target price adjustments for Syndax Pharmaceuticals reflect varied market sentiment.,Executive decisions on stock ...

Syndax Pharmaceuticals Inc (NASDAQ:SNDX) is set to release its Q4 2024 earnings on Mar 3, 2025. The consensus estimate for Q4 ...

At the close in NYSE,... Top Gainers: CMRX +14.1%. BBDO +6.4%. AKAO +5%. LPL +4.9%. SNDX +4.8%.Top Losers: LOOP -13.4%. GEMP -8.4%. DY -5.9%. GGB -4.9%. AGLE -4.9%.Now read: Achaogen Bags NTAP ...

Syndax Pharmaceuticals (SNDX) came out with a quarterly loss of $1.10 per share versus the Zacks Consensus Estimate of a loss of $1.08. This compares to loss of $1 per share a year ago. These figures ...

Citi lowered the firm’s price target on Syndax (SNDX) to $42 from $45 and keeps a Buy rating on the shares post the Q4 report. The firm says ...

SYNDAX PHARMACEUTICALS ($SNDX) posted quarterly earnings results on Monday, March 3rd. The company reported earnings of -$1.10 per share, missing estimates of -$0.25 ...

Scotiabank analyst George Farmer maintained a Hold rating on Syndax Pharmaceuticals (SNDX – Research Report) today and set a price target of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...